Chapter 1: Introduction to Theranostics (Shawn Chen/Stephen Wang/Wolfgang Weber)
Part I: In Vitro Theranostics (Editor: Stephen Wang)
This part will discuss in vitro biomarkers (genomic, proteomic and metabolomic) that can predict cancer therapy response.
Chapter 2: Introduction to theranostic biomarkers (Stephen Wong)
Chapter 3: Genomics based theranostics (Hua Zoghbi/Federico Monzo/Trey Westbrook)
Chapter 4: Proteomics based theranostics (Hanno Steen/Ching Lau/Paul Webb/Mauro Ferrari)
Chapter 5: Metabolomics based theranostics (Willa Hsueh/John Baxter/Ke Ma/Matthew Heiden)
Part II: Molecular Imaging (Editor: Wolfgang Weber)
This part will discuss how molecular imaging techniques can be applied to image the functional and molecular changes during cancer treatment and thus monitor/predict early response to cancer therapy.
Chapter 6: In vivo theranostic biomarkers (Hans Wester)
Chapter 7: Radionuclide imaging of cancer therapy (Helmut Mäcke)
Chapter 8: Optical imaging of cancer therapy (Vasilis Nziachristos)
Chapter 9: MR imaging of cancer therapy (Jürgen Hennig)
Chapter 10: Ultrasound imaging of cancer therapy (Fabian Kiessling)
Chapter 11: Multimodality imaging of cancer therapy (Johannes Czernin)
Part III: Imaging Guided Therapy (Editor: Stephen Wong)
This part will discuss how molecular imaging and interventional radiology techniques in dealing with cancer patients.
Chapter 12: Multimodality image-guided interventional systems (Kongkuo Lu/Zhong Xue)
Chapter 13: CARS for cancer diagnosis (Zhiyong Wang/Marc Cicerone)
Chapter 14: Multimodality image-guided treatment (investigators at JHMI/William Beaumont Hospital/University of Toronto)
Chapter 15: Medical Robotics (Dan Stoianovici/Guangzhong Yang/Gabor Fichtinger)
Part IV: Theranostic Platforms (Editor: Shawn Chen)
This part will discuss various combinations of imaging and therapy platforms especially composite nanoparticles.
Chapter 16: Optical imaging, PDT and PTT (Gang Zheng/Ick Chan Kwon)
Chapter 17: MR imaging and AMF (Shouheng Sun/Miqin Zhang/Jin Xie)
Chapter 18: Ultrasound and gene/drug delivery (Kathy Ferrara)
Chapter 19: Imaging isotope/therapy isotope (Fan Wang/David Yang, MD Anderson)
Chapter 20: Nobel metal nanoparticle platform (Younan Xia)
Chapter 21: Carbon nanomaterial platform (Zhuang Liu/Hongjie Dai)
Chapter 22: Silica nanoparticle platform (Leu-Wei Lo/Jeff Zink)
Chapter 23: Quantum dot nanoparticle platform (Xiaohu Gao/Shuming Nie)
Chapter 24: Polymer and protein platform (Zhe Wang/Xin Lin/Jinming Gao)
Part V: Other (Editor: Shawn Chen)
This part will discuss the practical issues with theranostics, such as the challenge of clinical translation and the market, as well as the future perspectives.
Chapter 25: Clinical translation and regulations of theranostics (Mauro Ferrari)
Chapter 26: Economy of theranostics (Omid Farokhzad/Bob Langer)
Chapter 27: Future perspectives (Jinwoo Cheon/Sam Gambhir)